Clinical Trials Logo

Transplantation, Kidney clinical trials

View clinical trials related to Transplantation, Kidney.

Filter by:
  • Available  
  • Page 1

NCT ID: NCT01236287 Available - Immunosuppression Clinical Trials

Special Access for the Use of Voclosporin for Kidney Transplantation

Start date: n/a
Phase:
Study type: Expanded Access

Voclosporin is an investigational medication previously studied to prevent acute rejection in patients who receive a kidney transplant. This study is a compassionate release program where subjects previously participating in the study entitled A Phase 2B, Randomized, Multicenter, Open-Label, Concentration Controlled, Safety Study of ISA247 and Tacrolimus (Prograf®) in denovo Renal Transplant Patients (ISA05-01)" may be eligible to continue to receive voclosporin despite the Phase 2B study being terminated by the sponsor. Under the compassionate release program, subjects previously taking voclosporin may continue to receive the study medication until the drug is FDA-approved and commercially available in the United States. Voclosporin was approved by the FDA in January 2021 for the treatment of active lupus nephritis. The sponsor (now called Aurinia Pharma, U.S.) is willing to continue to provide voclosporin (commercial supply) for the one subject remaining in this special access protocol.